1.An investigation of iodine level in drinking water and children iodine nutritional status in Chaoyang, Beijing in 2017
Yan LIANG ; Jianxin MA ; Lingjiao FU ; Zheng ZHANG ; Shuo WANG ; Jinming WEI
Chinese Journal of Endemiology 2019;38(3):227-230
Objective In order to know the baseline data of water iodine and the iodine nutritional status of 8-10 years old children in Chaoyang District of Beijing,to evaluate the current status of iodine deficiency disorders so as to provide a basis for taking targeted preventive measure and adjusting the intervention strategies scientifically.Methods Multi-stages sampling method was used to select drinking water samples from 43 subdistricts or townships in Chaoyang,and the water iodine content in the drinking water was determined.A cluster sampling method was applied to select 8-10 years old children from primary schools in 5 subdistricts or townships,and the iodine contents of urine and salt were determined.And B ultrasonic examination was carried out for diagnosis of thyroid disease.Results The median iodine content of drinking water in Chaoyang was 4.85 μg/L,the iodine content of self-provided wells (5.65 μg/L) was higher than that of municipal water (3.80 μg/L,Z =-3.469,P < 0.05).The coverage rate of iodized salt was 88.06% (177/201) and the qualified rate of iodized salt was 81.59% (164/ 201).The median urinary iodine was 165.00 μ g/L,median urinary iodine in boys (174.00 μg/L) was higher than that of girls (146.00 μg/L Z =-2.434,P < 0.05).The goiter rate diagnosed by B ultrasound was 1.49% (3/201),the thyroid nodule rate was 24.88% (50/201).Conclusions The iodine content of drinking water in the Chaoyang District is low,and it is still in the external environment of iodine deficiency (< 10 μg/L).The 8-10 years old children of Chaoyang show a good iodine nutritional status,however,neither the coverage rate nor the qualified rate of iodized salt has reached the standard of elimination of iodine deficiency disorders,and scientific iodine can not be ignored.
2.Analysis of influential factors for dose-corrected trough concentration of amisulpride based on therapeutic drug monitoring
Yiqi WANG ; Luyao CHANG ; Ran FU ; Lingjiao WANG ; Jing YU ; Chunhua ZHOU
China Pharmacy 2022;33(24):3020-3024
OBJECTIVE To analyze the influential factors for dose-corrected trough concentration (C/D) of amisulpride, and to provide reference for rational use of it in clinic. METHODS The results of the last serum concentration monitoring and relevant medical data of schizophrenic inpatients who were monitored for the treatment of amisulpride in the Mental Health Center of the First Hospital of Hebei Medical University from March to November 2021 were collected retrospectively and analyzed the effects of age, sex, body mass index (BMI), serum creatinine level, and combined medication on the C/D value of amisulpride. RESULTS A total of 133 schizophrenic inpatients were included, and median dose of amisulpride was 600.00 mg/d, median serum concentration was 332.57 ng/mL, and median value of C/D was 0.61 ng·d/(mL·mg). The serum concentration of 49 patients was within the recommended range of relevant guideline (100-320 ng/mL), and 27 patients exceeded the laboratory warning concentration (640 ng/mL). There was no statistical significance in drug dose, serum concentration or C/D value among the patients of different genders (P>0.05). The serum concentration of minor patients was significantly lower than that of adult patients (P<0.05), but there was no statistical significance in drug dose or C/D value between minor patients and adult patients (P>0.05). The C/D value of amisulpride in obese patients (BMI>28 kg/m2) was significantly lower than that in normal patients (BMI 18.5- 23.9 kg/m2); the combination of olanzapine, sodium valproate and benzodiazepines did not affect the C/D value of amisulpride (P>0.05); the level of serum creatinine in patients was not related to the dose of amisulpride (r=0.081, P>0.05), but was positively related to the C/D value of the drug (r=0.285, P<0.05). CONCLUSIONS The age, BMI and serum creatinine level of patients are closely related to the C/D value of amisulpride. In the clinical treatment of schizophrenia with amisulpride, we should fully consider the patient’s age, body mass, serum creatinine and other factors, and develop a personalized drug regimen for patients to ensure the safety and effectiveness of treatment.